TMC PULSE

Sept 2015 Pulse

Issue link: https://tmcpulse.uberflip.com/i/564353

Contents of this Issue

Navigation

Page 39 of 43

t m c » p u l s e | s e p t e m b e r 2 0 1 5 38 100% ONLINE RN TO BSN PROGRAM To request information, call 281-241-5412 or visit rntobsn.hbu.edu Offered through the School of Nursing and Allied Health, HBU's accelerated RN to BSN program prepares you for employability by offering an industry- aligned, Competency-Based Education that is both flexible and affordable. You can earn your BSN degree without having to travel to class. A Blood Test that Helps You Assess the Likelihood of Obstructive Coronary Artery Disease * Obstructive CAD is de ned as at least one atherosclerotic plaque causing ≥50% luminal diameter stenosis in a major coronary artery (≥1.5mm lumen diameter) as determined by invasive quantitative coronary angiography (QCA) or core-lab computed tomography angiography (CTA) (≥2.0mm lumen diameter). † The COMPASS study found that the Corus CAD algorithm has a sensitivity of 89% and an NPV of 96% at the pre-specified threshold of 15 in the overall population of men and women referred to MPI. References: 1. Thomas GS, Voros S, McPherson JA, et al. A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging: The COMPASS Study. Circ Cardiovasc Genet. 2013;6(2):154-162. 2. Rosenberg S, Elashoff MR, Beineke P, et al. Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients. Ann Intern Med. 2010;153:425-434. LEN-140052 Rev. 1 | ©2015 CardioDx, Inc. All rights reserved. CardioDx, the CardioDx logo, Corus, and the Corus logo are registered trademarks of CardioDx, Inc., in the U.S. and other countries. • SAFE Requires a simple blood draw, avoiding risks from radiation and contrast dye • CONVENIENT Administered in your of ce with results available within a few days • ACCURATE Demonstrates 96% negative predictive value and 89% sensitivity †1 • SEX-SPECIFIC Accounts for important cardiovascular differences between men and women 2 Corus ® CAD is the only blood test that, along with your clinical assessment, can help you rule out obstructive coronary artery disease (CAD) * in your symptomatic patients. To learn more, call 866.941.4996 or visit www.CorusCAD.com.

Articles in this issue

view archives of TMC PULSE - Sept 2015 Pulse